Jun 121 minCommercial ArticleS&P Global coverage of NovoBindNovoBind aims to move nanobodies from preliminary success into industrial studies by Joseph Harvey, editor of IHS Markit Animal Health.
Nov 13, 20201 minCommercial ArticleNovoBind brings NBX's to animal healthSingle domain antibody fragments will take overtake traditional antibodies in the coming years by Joseph Harvey, editor of IHS Markit Animal
Mar 12, 20201 minCommercial ArticleNovoBind addressing $22Billion in losses to producers“Precision biologics: the key to reducing antibiotic use in livestock? Combining the science of nanoencapsulation”